Prestigious Grant from the European Innovation Council Awarded to Tel Aviv University’s Research Team

Written on |

Dr. Iftach Nachman from the Faculty of Life Sciences leads the Israeli research team, as part of an international consortium.

The European Innovation Council Pathfinder Challenges program announced a 4.95M Euro funding to an international consortium from six countries. Dr. Iftach Nachman from the School of Neurobiology, Biochemistry & Biophysics at The George S. Wise Faculty of Life Sciences at Tel Aviv University leads the Israeli research team. The funding is given to an international consortium for the development of the Supervised Morphogenesis in Gastruloids (SUMO) project.

As part of the SUMO project, the researchers develop embryo like models (called ‘gastruloids’) based on pluripotent stem cells, to mimic cardiac and gastric tissues. With the help of advanced microscopy and machine learning, the consortium aims to make the gastruloids more robust and reproducible. The researchers hope that those models could be implemented in drug scanning and study of mutations in the future, and thus be a viable substitute to the use of lab animals.

Dr. Iftach Nachman: “In recent years the research field of embryonic models is seeing a huge boost. One of the main problems with growing such in-vitro stem-cell based models (and organoids in general) is the great variability between the different samples. We need to learn how to tame and control this variability to realize the promise of those models to the fields of medicine and basic science. This grant will enable us to deepen the scope of the research in this field.”

The SUMO consortium unites researchers from the University Hospital Oslo, Norway (HTH director: Stefan Krauss, coordinator), Max Planck Institute of Molecular Cell Biology and Genetics (MPI-CBG) (Jesse Veenvliet), Imperial College London, UK (HTH PI: Molly Stevens), University of Glasgow, UK (HTH PI: Nikolaj Gadegaard), Tel Aviv University, Israel (Iftach Nachman), Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Germany (Jens von Kries) and University of Oslo (HTH PI: Jan Helge Solbakk). 


European Innovation Council - Funded by the European Union

Related posts

“Super Seaweed” Produces Natural Health Compounds and Medicine from the Sea

20 March 2023

World’s First mRNA Vaccine Against Deadly Bacteria

15 March 2023

Do We Need ‘Junk DNA’?

15 March 2023

New Snake Family Identified

2 March 2023

Prof. Dan Peer Appointed as Member of the Prestigious American National Academy of Engineering

19 February 2023

Light Pollution is Killing Desert Rodents

10 February 2023

Three Tel Aviv University Researchers Awarded the ERC Proof of Concept (PoC) grants

9 February 2023

Five Tel Aviv University Researchers Win Prestigious ERC Grants

7 February 2023

Do You Have a Rightist or a Leftist Brain?

1 February 2023

Prof. Ehud Gazit Elected Fellow of the US National Academy of Inventors

25 January 2023

Researchers Uncover New Factors Linked to Williams Syndrome

24 January 2023

Robot, Can You Smell This?

23 January 2023

Tel Aviv University’s First MedTech Hackathon Sets a High Bar

15 January 2023

Researchers Identify 100,000 New Types of Viruses

27 December 2022

Could a Drone Save Bats from the Terror of Wind Turbine Blades?

19 December 2022

Breakthrough in the Field of Controlled Drug Delivery

16 December 2022


Tok Corporate Centre, Level 1,
459 Toorak Road, Toorak VIC 3142
Phone: +61 3 9296 2065

New South Wales

Level 22, Westfield Tower 2, 101 Grafton Street, Bondi Junction NSW 2022
Phone: +61 418 465 556

Western Australia

P O Box 36, Claremont,
WA  6010
Phone: :+61 411 223 550